29 June 2022Agrify enters highly attractive New Zealand cannabis marketOra Pharm becomes the second international customer to invest in Vertical Farming Units as Agrify continues to gain momentum with its ...Read More
28 June 2022Rua receives narcotic license through Nimbus Health for distribution and marketing of our first product for GermanyRua Bioscience Limited announced today that it has received its narcotic license through Nimbus Health GmbH for distribution and marketing of ...Read More
28 June 2022Greenfern secures lucrative export dealGreenfern Industries has secured a lucrative export deal that could be worth more than NZD$1.6m. Read more ...Read More
22 June 2022Greenfern Industries attains important industry certificationGreenfern Industries Limited is pleased to announce it has attained its globally-recognised GACP (Good Agriculture and Collection Practice) certification for its ...Read More
21 June 2022Cannasouth First Commercial Harvest. Media HighlightsCannasouth recently completed the first commercial harvest from our hybrid, controlled environment cultivation facility. This was a major milestone for us ...Read More
15 June 2022Greenlab joins forces with Helius Therapeutics to develop targeted medicinal cannabis treatmentsNew Zealand-based biotechnology company Greenlab has joined forces with licenced producer Helius Therapeutics to develop specialised and targeted medicinal cannabis treatments ...Read More
26 May 2022GFI sees growth in Australian medical cannabis prescriptionsGreenfern Industries’ GMP medicine prescription sales in the Australian market are going from strength to strength. Read more ...Read More
19 May 2022First products will deliver wider treatment optionsSuccessful assessment by the Medicinal Cannabis Agency of Cannasouth’s first medicinal cannabis products will deliver wider treatment options to New Zealand ...Read More
16 May 2022Delivery mode: Helius Therapeutics names new CCOJulie Curphey has been appointed Chief Commercial Officer (CCO) at Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company. Prior ...Read More
19 April 2022New licence – great news for Kiwi cannabis patientsHelius was New Zealand’s first medicinal cannabis business to achieve a GMP Licence for Manufacturing Medicines in July 2021, covering the ...Read More
19 April 2022Rua Bioscience launches its first medicine in New ZealandRua is one of just two companies in New Zealand manufacturing medicinal cannabis that has met the minimum quality standards as ...Read More
13 April 2022Helius teams up with University of Canterbury for wearables trialHelius Therapeutics has launched a collaboration with the University of Canterbury (UC) to test how accurately conditions such as stress ...Read More